Adriana L. Rocha

Ribeirao Preto, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Tamoxifen Therapy Is Associated With Altered Intestinal P-Glycoprotein Activity In Vivo.

Tamoxifen Therapy Is Associated With Altered Intestinal P-Glycoprotein Activity In Vivo.

Journal: Journal of clinical pharmacology

Published: May 25, 2026

LC-MS/MS quantification of endogenous taurine in plasma and urine using surrogate matrix calibration and background subtraction: Application to renal transporter phenotyping.

LC-MS/MS quantification of endogenous taurine in plasma and urine using surrogate matrix calibration and background subtraction: Application to renal transporter phenotyping.

Journal: Journal of pharmaceutical and biomedical analysis

Published: April 25, 2026

Enantioselective Pharmacokinetics of Venlafaxine in the Presence of CYP2D6 Inhibition: A Population Parent-Metabolite Modeling Approach.

Enantioselective Pharmacokinetics of Venlafaxine in the Presence of CYP2D6 Inhibition: A Population Parent-Metabolite Modeling Approach.

Journal: Journal of clinical pharmacology

Published: January 16, 2026

From Genotype to Therapeutic Monitoring: Enhancing Tamoxifen Efficacy in Breast Cancer Treatment.

From Genotype to Therapeutic Monitoring: Enhancing Tamoxifen Efficacy in Breast Cancer Treatment.

Journal: Journal of clinical pharmacology

Published: May 26, 2025

Characterization of Renal OAT3 and Hepatic CYP3A Activities in Pregnant Women with Acute Pyelonephritis Using the Endogenous Biomarker Cortisol and 6β-Hydroxycortisol.

Characterization of Renal OAT3 and Hepatic CYP3A Activities in Pregnant Women with Acute Pyelonephritis Using the Endogenous Biomarker Cortisol and 6β-Hydroxycortisol.

Journal: Journal of clinical pharmacology

Published: October 01, 2024

Liver Fibrosis Stages Affect Organic Cation Transporter 1/2 Activities in Hepatitis C Virus-Infected Patients.

Liver Fibrosis Stages Affect Organic Cation Transporter 1/2 Activities in Hepatitis C Virus-Infected Patients.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 10, 2024

Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter?

Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter?

Journal: Pharmaceutics

Published: June 07, 2024

Population Pharmacokinetic of the Diterpenes ent-Polyalthic Acid and Dihydro-ent-Agathic Acid from Copaifera Duckei Oil Resin in Rats.

Population Pharmacokinetic of the Diterpenes ent-Polyalthic Acid and Dihydro-ent-Agathic Acid from Copaifera Duckei Oil Resin in Rats.

Journal: Planta medica

Published: May 15, 2024

Biochemical characterization of an esterase from Thermobifida fusca YX with acetyl xylan esterase activity.

Biochemical characterization of an esterase from Thermobifida fusca YX with acetyl xylan esterase activity.

Journal: Molecular biology reports

Published: February 25, 2024

Intestinal P-gp activity is reduced in postmenopausal women under breast cancer therapy.

Intestinal P-gp activity is reduced in postmenopausal women under breast cancer therapy.

Journal: Clinical and translational science

Published: August 11, 2023

Determination of furosemide and its glucuronide metabolite in plasma, plasma ultrafiltrate and urine by HPLC-MS/MS with application to secretion and metabolite formation clearances in non-pregnant and pregnant women.

Determination of furosemide and its glucuronide metabolite in plasma, plasma ultrafiltrate and urine by HPLC-MS/MS with application to secretion and metabolite formation clearances in non-pregnant and pregnant women.

Journal: Journal of pharmaceutical and biomedical analysis

Published: May 24, 2023

Total, Unbound, Renal, and Hepatic Clearances of Raltegravir and the Formation and Elimination Clearances of Raltegravir Glucuronide in Pregnant Women.

Total, Unbound, Renal, and Hepatic Clearances of Raltegravir and the Formation and Elimination Clearances of Raltegravir Glucuronide in Pregnant Women.

Journal: Journal of clinical pharmacology

Published: March 20, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026